Engflag

Cal-MAG

Quick links to important sections

Cal-MAG

Cal-MAG_EN

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cal-MAG

Property Description
Active Ingredients Calcium (Ca), Magnesium (Mg), Vitamin D (Vit D), Boric Acid
Form Oral Solids (Tablets, Capsules) or Oral Liquids
Pharmacological Class Vitamin-Mineral Supplement, Essential Micronutrient Complex
General Purpose Foundational Bone and Muscle Support, Homeostasis
Origin Derived (chemically defined salts and vitamins)

Cal-MAG: Defining the Vitamin-Mineral Combination

The Cal-MAG formulation is a specialized combination product classified as an essential vitamin-mineral supplement that serves as an Electrolyte and Bone Health Agent. It is designed to provide systemic nutritional support, distinguishing itself from single-entity preparations by supplying multiple components necessary for optimal balance, particularly in bone metabolism and muscle function. This supplement is primarily presented in oral solids, such as capsules or tablets, intended for the oral route of administration. The combination approach is described as promoting enhanced mineral utilization compared to single supplements; the efficacy of calcium absorption is dependent on vitamin D status.

Active Components and Chemical Forms of Cal-MAG

The core of Cal-MAG's composition features the active ingredients Calcium, Magnesium, and Vitamin D, often alongside the trace element source Boric Acid. These essential substances are typically integrated as salts to enhance their absorption; for instance, Calcium may be supplied as Calcium Carbonate or Calcium Gluconate, while Magnesium may be present as Magnesium Oxide or Magnesium Chloride. The inclusion of Vitamin D (typically Cholecalciferol) is critical as it chemically facilitates the intestinal absorption of Calcium. Calcium and magnesium are regarded as foundational in human health, and maintaining adequate intake is necessary for preventing deficiency-related physiological issues.

General Purpose and Physiological Support

The general purpose of Cal-MAG is to contribute to foundational physiological homeostasis by ensuring adequate mineral availability for the body's structural and functional needs. The minerals work in tandem to support fundamental processes, with Calcium being the primary component for skeletal matrix formation, and Magnesium acting as a necessary cofactor in enzymatic processes that regulate muscle contraction and stable nerve impulse transmission. A typical neutral use scenario for this combination is ongoing support for individuals whose diet may not reliably supply sufficient amounts of all three primary micronutrients. Consequently, using this supplement aids in maintaining long-term bone density and supports the normal function of both the muscular and nervous systems, supporting overall systemic integrity.

Regulatory References

  1. National Institutes of Health (NIH)
  2. muscle contraction

What side effects are possible with Cal-MAG?

Possible Side Effects and Safety Information

Adverse effects related to Cal-MAG formulations primarily involve the gastrointestinal system and allergic reactions. The occurrence of side effects is typically dose-dependent, with higher intakes of magnesium being more likely to cause symptoms.

System-Organ Class Common/Expected Adverse Reactions
Gastrointestinal Upset stomach, vomiting, diarrhea, constipation

Serious Adverse Reactions

Consult a healthcare professional immediately if any signs of a severe or serious adverse reaction occur. These can include:

  • Allergic Reaction: Symptoms such as rash, hives, difficulty breathing or swallowing, wheezing, tightness in the chest or throat, or swelling of the face, mouth, tongue, or throat.
  • Severe Gastrointestinal Upset: Very upset stomach or persistent, severe vomiting.
  • Hypermagnesemia (Magnesium Overload): If excessive amounts of magnesium are consumed, signs of toxicity can occur, particularly in individuals with reduced kidney function. Symptoms may include flushing, low blood pressure (hypotension), muscle weakness, and respiratory depression. Cardiovascular collapse can occur at very high serum levels.

Population-Specific Safety Notes

Safety concerns for calcium and magnesium may vary in specific patient populations:

  • Renal Impairment: Individuals with impaired kidney function must be monitored closely, as they may have difficulty excreting magnesium, leading to an increased risk of hypermagnesemia and subsequent toxicity.
  • Pregnancy: Long-term or high-dose intravenous administration of magnesium sulfate in pregnant women has been associated with low calcium levels and bone problems in the developing baby, including thin bones (osteopenia) and bone fractures. Use of magnesium during pregnancy should be carefully managed by a healthcare provider.

Cal-MAG is generally classified as a vitamin and mineral combination. Adverse reactions are reported to regulatory bodies, such as the FDA's MedWatch program, when identified.

Overdose and Emergency Response

The official regulatory profile for Cal-MAG overdose centers on the manifestations of Hypercalcemia and Hypermagnesemia, stemming from excessive intake of its active mineral and vitamin components. Documented presentations include gastrointestinal effects (nausea, vomiting, constipation, anorexia) and renal effects such as excessive thirst (polydipsia) and urination (polyuria). Neurological signs like drowsiness, confusion, and muscle weakness are also explicitly listed in official labeling.

When to Seek Urgent Medical Help

Immediate medical attention is required for any suspected overdose event. Regulatory documents mandate that emergency services must be contacted immediately if signs of severe systemic compromise occur, particularly those involving the Cardiovascular or Central Nervous System. Severe, life-threatening outcomes documented in the labeling include profound hypotension, cardiac arrhythmia, respiratory depression, and acute renal failure.

Required Supportive Actions

Upon suspicion of overdose, immediate discontinuation of the product is mandated. Management is primarily symptomatic and supportive treatment, including the use of intravenous fluid administration and, in refractory cases, procedures like hemodialysis. The official guidance confirms that no specific antidote is known. Hospital monitoring is required, specifically continuous ECG monitoring and monitoring of serum electrolytes and renal function, with an explicit note regarding the increased risk of toxicity in patients with impaired renal function.

Therapeutic Uses of Cal-MAG

The combined Cal-MAG supplement is applied across domains where additional symptomatic support is needed, assisting with the management of symptoms related to systemic imbalance and temporary discomfort. The combination is relevant when supportive symptom management is appropriate for conditions where functional stability becomes affected. This aligns with the recognized supportive roles of its components. Magnesium is considered relevant for easing symptoms that interfere with daily functioning, particularly those related to symptoms of increased neurological or muscular activity.

Symptomatic Domains of Use

Cal-MAG is generally used to help address symptom clusters that may become intense or disruptive. The brief listing of indications includes symptomatic support for: Muscle and Neuromuscular Tension (such as spasms and cramps); Manifestations of Heightened Nervous Tension (like temporary nervousness or restlessness); and Acute Digestive Discomfort (including occasional acid indigestion or heartburn).

This supportive management is helpful in situations requiring additional symptomatic assistance when symptoms intensify and supportive relief is needed.

Key Therapeutic Benefit

This combination is applied when symptoms create noticeable physiological strain, offering symptomatic relief that supports the patient during difficult episodes by easing distress. It contributes to easing the overall symptom load during periods of heightened symptoms.

Symptom Focus: Relief for Acute Symptomatic Discomfort The supplement is commonly used across conditions presenting with acute episodes, offering short-term symptomatic assistance, and contributes to easing the overall symptom load.

Eligibility and Restrictions for Use

Who can and cannot use Cal-MAG? — Official Regulatory Information

Regulatory documents establish clear boundaries for the use of the Cal-MAG combination supplement, primarily based on the risk of mineral overload.

Contraindicated Populations
Patients with hypercalcemia (high blood calcium) or severe hypercalciuria (excessive calcium excretion).
Individuals with known hypersensitivity to Calcium, Magnesium, or Vitamin D components.
Condition-Specific Limitations
Severe renal impairment may be a contraindication or necessitate restricted use due to the risk of mineral accumulation.
Use requires caution in patients with a history of kidney stones or conditions like sarcoidosis.
Age and Developmental Status
Use is often not recommended for children under 12 years of age, as safety data may be limited for some formulations.
During pregnancy and lactation, use is generally permitted to address nutritional needs but must strictly adhere to dose limits for the Vitamin D component.

What should I know about interactions with other medicines?

The interaction profile for Cal-MAG is primarily defined by the physicochemical properties of its Calcium and Magnesium components, which can affect the absorption and systemic effects of co-administered substances, as documented in regulatory sources.

Exposure-Modifying Interactions (Reduced Absorption)

Co-administration of Cal-MAG with certain oral medications can lead to a reduction in the systemic exposure of the interacting medicine. This is due to the formation of insoluble complexes in the gastrointestinal tract, as described in official labeling.

Interacting Medicine Class Official Regulatory Note
Quinolone/Tetracycline Antibiotics Absorption and efficacy are diminished; requires mandatory dose separation.
Thyroid Hormones (e.g., Levothyroxine) Reduced absorption is documented; requires mandatory separation of administration time.
Bisphosphonates Significant reduction in bioavailability; requires mandatory dose separation.
Iron/Zinc/Fluoride Preparations Reduced absorption of these substances is officially documented.

Pharmacodynamic Interactions

Additive effects are officially noted with specific classes of medicines:

  • Cardiac Glycosides (e.g., Digoxin): Co-use may increase the risk of cardiac arrhythmia due to potential hypercalcemia, which is a documented risk requiring caution.
  • Thiazide Diuretics: Concurrent use with Calcium and Vitamin D reduces urinary calcium excretion, increasing the risk of developing hypercalcemia.
  • Neuromuscular Blocking Agents: Magnesium may potentiate the effects, potentially leading to enhanced neuromuscular depression.

Timing and Population Constraints

To mitigate the risk of reduced exposure, regulatory labeling mandates a mandatory administration separation (typically 2 to 6 hours) between Cal-MAG and affected antibiotics, bisphosphonates, and thyroid hormones. In populations with renal impairment, the risk and severity of pharmacodynamic interactions are heightened due to reduced mineral clearance. Specific dietary components, such as Oxalic acid (in spinach) and Phytic acid (in whole grains), are officially documented to reduce the absorption of the Calcium component.

Mechanism of Action

The action of Cal-MAG is defined by the fundamental biological roles of Calcium (Ca^2+) and Magnesium (Mg^2+) ions, engaging multiple regulatory pathways to influence cellular ion-flux regulation and systemic mineral homeostasis.

Modulating Neuromuscular Excitability

This domain covers the critical ion-gating mechanisms in nerve and muscle cells. Magnesium acts as a physiological calcium antagonist, binding to receptors and channels to dampen excessive Ca^2+ influx necessary for contraction and nerve firing. This interaction modulates overactive signaling, which results in an elevated threshold for action potential generation in excitable tissues.

Supporting Cellular Energy and Enzyme Function

Magnesium is essential as an obligate cofactor for hundreds of enzyme systems, most importantly those involved in cellular energy production. It must complex with ATP (Adenosine Triphosphate) to form the biologically active Mg-ATP complex, which fuels virtually all metabolic processes. This mechanism is requisite for the catalytic activity and structural stability of key cellular cascades.

Regulating Mineral and Bone Homeostasis

This involves the systemic hormonal loops that control mineral balance. Calcium is the structural component of the bone matrix, while Magnesium is required as a cofactor for the enzymatic activation of Vitamin D and for Parathyroid Hormone (PTH) signaling. This combined action modulates hormonal signaling pathways that control blood calcium levels and mineral turnover.

Influencing Vascular Tone

In the cardiovascular system, Magnesium acts directly on the vascular smooth muscle cells. By competing with Ca^2+ for entry via calcium channels, Mg^2+ reduces the intracellular trigger for muscle contraction, thus promoting vasodilation (relaxation). This mechanism induces changes in vascular smooth muscle tone by altering contractile state.

Dosage and Administration Information

How to Use Cal-MAG: Administration Guidelines

The usage of Cal-MAG, an essential vitamin-mineral complex, is governed by administration principles designed to optimize the absorption and utilization of its core components: Calcium, Magnesium, and Vitamin D. The established route for this supplement is Oral ingestion, available in forms such as tablets, capsules, or liquid suspensions.

Dosing and Frequency Patterns

Administration follows a daily pattern, often intended for long-term maintenance or, in certain contexts, short-term symptomatic assistance. Standard adult regimens typically aim to supplement dietary intake up to a total daily elemental Calcium goal of 1,000 mg to 1,200 mg.

To maximize the intestinal absorption of Calcium, it is often recommended to take the total daily dose in divided portions; typically, doses should not exceed 500 mg of elemental calcium at one time. Guidelines typically specify not exceeding the established Tolerable Upper Intake Level (UL) for the components, which may be up to 2,500 mg total elemental Calcium for adults.

Contextual Use and Administration Conditions

Administration Condition Instruction Rationale
Timing in Relation to Meals Taken with or immediately after a meal to enhance the absorption of components. The presence of food facilitates Vitamin D's action on calcium absorption.
Preparation for Liquid Forms Liquid or suspension forms require shaking before use and accurate measurement with a calibrated dosing tool. Required for homogeneity and dose precision.
Special Procedural Constraint Administration is time-separated by several hours from certain other oral medications (e.g., some antibiotics) to prevent chelation and subsequent reduction in the absorption of the other drug. Prevents reduced efficacy of co-administered drugs.

For specific populations, such as older adults (≥ 51 years), daily intake targets for elemental Calcium and Vitamin D are often noted as higher than for younger adults. These procedural considerations are associated with supporting proper mineral utilization.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Cal-MAG

Evidence for Foundational Skeletal Health

Research exploring the role of Cal-MAG components in skeletal outcomes was studied for the combination of Calcium and Vitamin D. Researchers have conducted large-scale Randomized Controlled Trials (RCTs) and comprehensive meta-analyses that observed the effects of these micronutrients. These trials primarily measured changes in structural health indicators, such as Bone Mineral Density (BMD) measurements and how often fractures were reported over time.

The populations evaluated often included older adults, especially postmenopausal women, who were relevant in evidence describing how symptoms are measured, along with individuals confirmed to have low levels of Vitamin D. Studies also monitored biochemical measures, such as levels of 25-hydroxyvitamin D, which is used as an indicator of nutrient status.

The findings describe patterns observed in the studies. For individuals with documented low baseline levels, research highlights changes measured during the study period, reporting shifts in nutrient biomarkers in the observed populations. In institutionalized or high-risk populations, some studies monitored outcomes related to skeletal outcomes and reported patterns observed in the studies compared to those receiving placebo, but findings were mixed. However, evidence is limited and findings were mixed when looking at healthy, community-dwelling populations who already had sufficient calcium intake, with some large trials reported no differences in fracture patterns.

Evidence for Supportive Relief from Muscle and Neuromuscular Tension

Research exploring how symptoms change over time, and used in studies examining patient-reported experiences of outcomes related to systemic or functional imbalance (such as muscle and neuromuscular tension), is mainly focused on the Magnesium component of Cal-MAG. This research explored short-term symptom changes, primarily through short-term Randomized Controlled Trials (RCTs), comparing magnesium against a placebo. These trials monitored outcomes describing episodic or acute changes, specifically tracking outcomes related to skeletal muscle cramp frequency and intensity or duration.

The primary groups evaluated in these studies were older adults relevant in trials assessing short-term or episodic symptom patterns (such as rest cramps) and pregnant women who had associated cramps. These studies focused on episodes where symptoms become more noticeable, observing responses over defined time intervals that were typically short, often lasting only four to six weeks.

Studies report how symptoms evolved in the observed populations, with some trials reporting that individuals in the magnesium groups had differences in the measured frequency or intensity of cramps compared to control groups. However, when multiple trials were analyzed together in systematic reviews, the evidence suggests that for idiopathic cramps in older adults, the overall findings were mixed, and certainty remains low regarding a consistent, meaningful change in symptom patterns. The findings help contextualize how patients reported their experience, but research does not determine whether an individual will respond similarly.

Long-Term Studies and Follow-up Data

The research base for Cal-MAG's components varies significantly in duration depending on the outcome being monitored. For the core skeletal outcomes, researchers have studied the Calcium and Vitamin D combination over longer-term periods, with some key trials lasting up to three to seven years to measure fracture incidence. These studies provide context but not individual predictions regarding the durability of nutrient support and bone status.

In contrast, the research related to outcomes describing episodic or acute changes (such as muscle tension) is largely drawn from short-term studies, where follow-up durations were limited, typically spanning only a few weeks to a couple of months. Therefore, long-term effects are not fully established regarding the patterns of episodic symptom changes.

Evidence in Key Population Subgroups

Specific research was evaluated in distinct population subgroups, primarily due to their nutritional needs or physiological states. The evidence for foundational skeletal health largely applies to older adults and postmenopausal women, as studies were conducted during periods of increased risk for skeletal changes. Furthermore, the outcomes related to physical discomfort were explored in pregnant women experiencing associated cramps. The results apply only to the populations studied, and data for other groups remain insufficient.

Study Landscape: Evidence Quality and Research Gaps

The evidence quality varies across studies, with the highest-level evidence (large RCTs and meta-analyses) which evaluated the combined role of Calcium and Vitamin D in managing deficiency and maintaining nutrient status in at-risk groups.

Despite this, several research limitations and gaps exist. One key limitation is that the strongest evidence for skeletal health focuses almost exclusively on the Calcium and Vitamin D pairing, meaning there is limited information for the specific role or impact of the full Cal-MAG formulation, including the added Magnesium and Boric Acid, in major fracture trials. The consistency of findings is another area of uncertainty, as trial results can differ significantly based on the population's baseline dietary intake and existing nutrient status.

Finally, while studies contribute to the broader evidence landscape, subgroup findings are uncertain, and the sample sizes were modest for the magnesium research into muscle tension relief. Research is ongoing to better understand these complexities.

Key Studies & References

  1. Vitamin D and Calcium: A Systematic Review of Health Outcomes

Frequently Asked Questions (FAQ)

Common questions about Cal-MAG (FAQ)

Q: How quickly should I expect to see an effect from Cal-MAG?

Information from research studies indicates that the time it takes to observe effects can vary significantly based on the intended health outcome. Studies examining foundational skeletal health often require longer observation periods, sometimes spanning several years. Conversely, research looking at episodic symptoms, such as muscle tension, typically observes changes over much shorter intervals, such as a few weeks to a couple of months.

Q: Can Cal-MAG cause stomach upset or digestive issues?

Regulatory documents state that adverse effects related to Cal-MAG formulations primarily involve the gastrointestinal system. These effects, which include upset stomach, vomiting, diarrhea, and constipation, are typically reported as being dose-dependent.

Q: Are the side effects of Cal-MAG generally mild?

Official documentation lists expected adverse reactions that are primarily common gastrointestinal issues. However, the same documentation also lists serious adverse reactions, such as signs of a severe allergic reaction or hypermagnesemia (magnesium overload), which are listed as requiring consultation with a healthcare professional.

Q: Does Cal-MAG affect sleep or energy levels?

While Cal-MAG components influence neuromuscular excitability and cellular energy, symptoms that may affect energy are associated with mineral overload. Extremely high levels of calcium (hypercalcemia) or magnesium (hypermagnesemia) are listed in regulatory sources as potentially leading to symptoms like lethargy or unusual weakness and fatigue.

Q: Can Cal-MAG be taken with a general multivitamin?

Regulatory sources advise caution when combining Cal-MAG with other supplements. It is specifically warned that taking additional non-prescription supplements containing extra Calcium, Magnesium, Vitamin D, or Phosphorus can increase the risk of side effects. Additionally, the absorption of other mineral supplements, such as Iron and Zinc, is officially documented to be reduced if taken concurrently with Cal-MAG.

Q: Does Cal-MAG interact with alcohol?

Official regulatory notes indicate that heavy alcohol drinking may make it harder for the body to absorb the calcium component of Cal-MAG. It is described that the use of alcohol should be discussed with a healthcare professional.

Q: How does Cal-MAG relate to bone health?

Cal-MAG is generally classified as an Electrolyte and Bone Health Agent. Its purpose is to support foundational structural needs, with Calcium being the primary component for skeletal matrix formation. The Magnesium and Vitamin D components help modulate the hormonal signaling pathways necessary for healthy blood calcium levels and mineral turnover.

Q: How is Cal-MAG cleared from the body?

The body clears excess magnesium and calcium primarily through the kidneys. Because of this clearance pathway, individuals with impaired kidney function must be monitored closely, as they may have difficulty excreting the minerals, leading to an increased risk of mineral accumulation.

Q: What is the difference between Cal-MAG and other common magnesium/calcium products?

Cal-MAG is classified in official documents as a specialized combination product that supplies multiple essential components—Calcium, Magnesium, and Vitamin D—together. This distinguishes it from single-entity preparations that contain only one vitamin or mineral.

Q: Can teenagers or young adults use Cal-MAG?

Official documents state that use is often not recommended for children under 12 years of age, due to limited safety data for some formulations. For those aged 14 to 18 years, authorities like the NIH Office of Dietary Supplements have established specific Recommended Dietary Allowances (RDAs) for calcium and magnesium.

Q: Is Cal-MAG appropriate for older adults?

Official health authorities frequently define higher daily intake targets for elemental Calcium and Vitamin D for older adults (aged 51 years and above) compared to younger adults. Furthermore, research studies evaluating skeletal health outcomes often include this population.

Q: What happens if I accidentally take too much Cal-MAG?

In the event of a suspected overdosage, official protocols advise contacting a poison control center or emergency room at once. Overdosage is described as potentially leading to severe adverse reactions, including signs of mineral toxicity such as hypermagnesemia (magnesium overload) or hypercalcemia (high calcium levels).

Q: Why are there so many different forms of Cal-MAG available?

The minerals in Cal-MAG are typically supplied as various salts (e.g., Calcium Carbonate or Magnesium Oxide) to influence their absorption or presentation. The use of different chemical forms allows manufacturers to formulate products optimized for stability and utilization.

Q: Does Cal-MAG help with muscle cramps?

Research has explored the Magnesium component of Cal-MAG in relation to outcomes describing episodic changes in skeletal muscle cramp frequency and intensity. However, evidence indicates that findings were mixed regarding a consistent, meaningful change in symptom patterns.

Q: Is it possible to be allergic to Cal-MAG?

Official documents list known hypersensitivity to Calcium, Magnesium, or Vitamin D components as a contraindication for use. Signs of a severe allergic reaction, such as a rash, hives, or difficulty breathing, are also listed as serious adverse reactions that are listed as requiring consultation with a healthcare professional.

Q: Is it normal to feel slightly dizzy after starting Cal-MAG?

Dizziness or feeling lightheaded is listed in regulatory sources as a symptom that may be associated with high calcium levels (hypercalcemia). If such a symptom occurs, it is described as requiring consultation with a healthcare professional.

Q: Can people with diabetes use Cal-MAG?

Authoritative documents indicate that people with diabetes should use Cal-MAG with caution. The condition itself may increase the risk for magnesium deficiency, and official documents describe that the magnesium component may interact with some classes of diabetes medications (like sulfonylureas), which requires careful monitoring.

Q: Does Cal-MAG interact with blood pressure medication?

Official documentation notes that co-use may potentially interact with specific classes of blood pressure medication. This includes Thiazide Diuretics, which increase the risk of hypercalcemia, and Calcium Channel Blockers, which may increase the risk of low blood pressure.

Q: Is Cal-MAG used for preventive reasons?

The supplement is described in official documents as contributing to foundational physiological homeostasis. It is used for ongoing nutritional support to aid in maintaining long-term bone density and supporting the normal function of the muscular and nervous systems.

Q: Are there different recommended amounts of Cal-MAG based on gender?

Recommended Dietary Allowances (RDAs) established by authorities like the NIH Office of Dietary Supplements for the individual components of Cal-MAG do vary based on demographics. Specifically, the RDAs for both the Calcium and Magnesium components are different between men and women, and between teen boys and teen girls.

Q: Why do some people report Cal-MAG causing tiredness?

Symptoms such as tiredness or lethargy are listed in regulatory sources as signs that may be associated with high calcium or magnesium levels (hypercalcemia or hypermagnesemia). These are potential signs of mineral overload which are listed as requiring medical attention.

Q: Does Cal-MAG interact with common heart medications?

Co-use is officially noted to potentially interact with specific classes of heart medications. This includes Cardiac Glycosides (due to the risk of cardiac arrhythmia) and some blood pressure medications like Calcium Channel Blockers, which act on the cardiovascular system.

Q: Is there research on Cal-MAG's use in athletes?

Authoritative research documents have examined the role of the individual components of Cal-MAG in physically active individuals. Specifically, the roles of Magnesium and Vitamin D have been studied in athletes, with some evidence suggesting physically active individuals may have higher magnesium requirements due to increased metabolism and muscle function needs.

Q: If I take other mineral supplements, can I still take Cal-MAG?

Regulatory sources caution against taking non-prescription supplements that contain extra Calcium, Magnesium, Vitamin D, or Phosphorus while using Cal-MAG. Additionally, the absorption of other mineral supplements like Iron and Zinc is documented to be reduced if they are taken concurrently with Cal-MAG components.

Q: Do I need to stop taking Cal-MAG before a surgery?

The Magnesium component may potentiate the effects of Neuromuscular Blocking Agents, which are used during surgery, potentially leading to enhanced neuromuscular depression. Official guidelines indicate it is important to inform a healthcare provider or anesthesiologist about all supplements being taken before any surgical procedure.

Q: What information is available about Cal-MAG and mental health?

Official documents mention that very high levels of magnesium (hypermagnesemia) may lead to central nervous system effects. Symptoms listed in this context include confusion or depression.

How should Cal-MAG be stored and disposed of?

How to Store and Dispose of Cal-MAG

Official regulatory guidance dictates specific storage and disposal requirements for Cal-MAG (Calcium and Magnesium Supplement) to maintain its stability and ensure safety.

Requirement Area Official Instructions
Storage Conditions Store at controlled room temperature (below 30 C) in a dry place. Protect from light and do not freeze.
Container & Handling Keep the container tightly closed and store the product out of the sight and reach of children and pets.
Disposal The preferred method is using a drug take-back program. If unavailable, unused product must be mixed with an unappealing substance (like dirt or used coffee grounds), sealed in a bag, and placed in the household trash. Do not flush or pour down any drain.

These instructions maintain the product's integrity and align with environmental protection and public safety protocols for non-controlled supplements.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Cal-MAG found in:

A-Z Index: